Zynerba Pharma (ZYNE) Reports Q1 Loss of $0.60/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Zynerba Pharmaceuticals Reports First Quarter 2017 Financial ResultsĀ and Operational Highlights
May 9, 2017 7:30 AM EDTDEVON, Pa., May 09, 2017 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), a clinical-stage... More



